HKSE:02607'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.14 Med: 2.2 Max: 3.94
Current: 3.79
During the past 13 years, the highest Dividend Yield of Shanghai Pharmaceuticals Holding Co was 3.94%. The lowest was 1.14%. And the median was 2.20%.
HKSE:02607's Dividend Yield % is ranked worse than 55.07% of 69
companies
in the Medical Distribution industry
Industry Median: 2.94
vs HKSE:02607: 3.79
During the past 13 years, the highest Dividend Payout Ratio of Shanghai Pharmaceuticals Holding Co was 0.63. The lowest was 0.23. And the median was 0.34.
During the past 12 months, Shanghai Pharmaceuticals Holding Co's average Dividends Per Share Growth Rate was -16.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -0.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 0.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 4.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shanghai Pharmaceuticals Holding Co was 52.60% per year. The lowest was -42.60% per year. And the median was 10.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Shanghai Pharmaceuticals Holding Co (HKSE:02607) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pharmaceuticals Holding Co Dividend Yield % Chart
HKSE:02607 vs MCK, CAH, COR: Dividend Yield % Comparison
For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Pharmaceuticals Holding Co Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Dividend Yield % falls into.
Shanghai Pharmaceuticals Holding Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Shanghai Pharmaceuticals Holding Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.132150
2025-12-29
2025-12-31
2026-02-06
Cash Dividend
semi-annually
HKD:HKD 1.000000
HKD 0.316970
2025-07-16
2025-07-17
2025-08-25
Cash Dividend
semi-annually
HKD:HKD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pharmaceuticals Holding Co (HKSE:02607) has a Dividend Yield % of 3.79% as of Jun. 30, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. This is 72% above median its historical median of 2.20. Over the past decade, Shanghai Pharmaceuticals Holding Co's Dividend Yield % has ranged from 1.14 to 3.94. According to the industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #38 out of 69 companies in the Medical Distribution industry, placing it in the top 55.1%.
Is Shanghai Pharmaceuticals Holding Co's Dividend Yield % too high?
Shanghai Pharmaceuticals Holding Co's current Dividend Yield % of 3.79% is 72% above median its 10-year median of 2.20. Over the past 10 years, this metric has ranged from a low of 1.14 to a high of 3.94. The Medical Distribution industry median Dividend Yield % is 2.94. Shanghai Pharmaceuticals Holding Co's value of 3.79% is 28.9% above this industry median. Based on the distribution chart, Shanghai Pharmaceuticals Holding Co ranks #38 out of 69 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Dividend Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #38 out of 69 companies for Dividend Yield %. This places Shanghai Pharmaceuticals Holding Co in the lower half of its industry. The industry median Dividend Yield % is 2.94. Shanghai Pharmaceuticals Holding Co's value of 3.79% is 28.9% above this benchmark. Historically, Shanghai Pharmaceuticals Holding Co's own Dividend Yield % has ranged from 1.14 to 3.94 over the past decade. While the company's 10-year median is 2.20 vs. the industry median of 2.94, Shanghai Pharmaceuticals Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.94, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Pharmaceuticals Holding Co's current Dividend Yield % of 3.79% is 28.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Pharmaceuticals Holding Co's current Dividend Yield % is 3.79%, which is 72% above median its own 10-year median of 2.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co (HKSE:02607) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$14.75, compared to a current price of HK$11.40 — trading 22.7% below its estimated fair value. The current Dividend Yield % is 3.79%, which is 72% above median its 10-year median of 2.20 and 28.9% above the Medical Distribution industry median of 2.94. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (HKSE:02607), the current Dividend Yield % is 3.79% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Pharmaceuticals Holding Co (HKSE:02607) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued.
The current stock price of HK$11.40 is trading 22.7% below its estimated GF Value™ of HK$14.75.
GuruFocus considers Shanghai Pharmaceuticals Holding Co to be Modestly Undervalued.
Key valuation signals for HKSE:02607:
Dividend Yield %: 3.79% (72% above median its 10-year median of 2.20)
GF Value™: HK$14.75 vs. price of HK$11.40 (22.7% below fair value)
Industry Position: 28.9% above the Medical Distribution median (#38 of 69)
No single metric tells the full story. See the HKSE:02607 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Pharmaceuticals Holding Co Business Description
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
87GF Score
Get the complete analysis for HKSE:02607
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02607 has been successfully added to your 
